The Cancer Research Institute mission is save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. It funds research aimed at furthering the development of immunological approaches to the diagnosis, treatment, and prevention of cancer.
To this end, CRI offers its Clinic and Laboratory Integration Program (CLIP) Grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The program supports pre-clinical and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic.
In partnership with the Chordoma Foundation (CF), CRI has secured designated funding that will provide for additional CLIP grants focused on topics related to accelerating the development of effective treatments and ultimately a cure for chordoma, a rare type of cancer that occurs in the bones of the skull base and spine. Proposals in this area are encouraged. Please be advised that CF has chordoma models and banked tumor samples that are available to the research community. For more information on this, please email email@example.com.
The development of new and effective cancer treatment requires the translation of basic laboratory discoveries into novel therapies that can be tested in patients. This area of translational research—where laboratory findings move into clinical testing, and where questions from clinical studies are brought back into the lab—is critical to bringing new and better immunotherapies to patients.
The Cancer Research Institute established CLIP to support investigators who are studying critical topics at the intersection of laboratory and clinical research. CLIP grants provide up to $200,000 over a two-year period.
View our funding directory to see the types of research CLIP investigators are working on to change the face of cancer treatment.
See Application Guidelines and Apply